Tag: Gennova Biopharmaceuticals ltd

To address the shortage of Covid-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside... Read More

A crucial part of India's fight against second Covid-19 wave is vaccination. The country has an uphill task to inoculate about 850 million (85 crore) people over the age of... Read More

Pune: The Union government is rapidly ramping up production of three approved vaccines — Covaxin, Covishield and Sputnik V — to cover everyone over 18 from May 1, a top... Read More

US-based bio-pharmaceutical company HDT Bio Corp on Wednesday announced the start of Phase III trial of its COVID-19 vaccine in India. The Phase III trial of the vaccine developed by HDT... Read More

Amid an acute shortage of COVID-19 vaccines across the country, NITI Aayog member Dr VK Paul on Thursday said that India will have 216 crore vaccine doses by the year-end... Read More

Gennova Biopharmaceuticals, which is working on India’s first mRNA Covid-19 vaccine, is in the midst of Phase-I trials of its Covid-19 vaccine (HGC019). Vikas Thapar, president – corporate development &... Read More

The Department of Biotechnology (DBT), Ministry of Science & Technology has announced that it has approved additional funding towards clinical studies of India's 'first of its kind' mRNA-based COVID-19 vaccine... Read More

The word may remind us about the science fiction trilogy Matrix, but in reality this Matrix M adjuvant uses extracts from Soapbark trees called Quillaja Saponins (QS), grown in the... Read More

The Pune-headquartered company, a subsidiary of Emcure Pharmaceuticals, had received approval in December last year to start phase 1 and 2 trials for its COVID-19 vaccine candidate. However, it got... Read More

India's mRNA-based covid-19 vaccine candidate-HGCO19, developed by Pune-based biotechnology company Gennova Biopharmaceuticals Ltd has received additional government funding for its clinical studies. The department of biotechnology (DBT), ministry of science &... Read More